Evidence map›Paper›PMID 38806708›Full record

ArticleNature immunology2024

Nociceptor-immune interactomes reveal insult-specific immune signatures of pain.

Aakanksha Jain, Benjamin M Gyori, Sara Hakim, Ashish Jain, Liang Sun, Veselina Petrova, Shamsuddin A Bhuiyan, Shannon Zhen, Qing Wang, Riki Kawaguchi and 9 more

Abstract read
In one paragraph

Article in Nature immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pathogenic Role of FGFR3 Autoantibodies in Small Fiber Neuropathy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Lysophosphatidylcholine sensitizes TRPV2 by indirect mechanisms.Pflugers Archiv : European journal of physiology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Aakanksha JainF. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.
Benjamin M GyoriLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9439-5346
Sara HakimF. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.
Ashish JainResearch Computing, Department of Information Technology, Boston Children's Hospital, Boston, MA, USA.
Liang SunResearch Computing, Department of Information Technology, Boston Children's Hospital, Boston, MA, USA.
Veselina PetrovaF. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5593-0198
Shamsuddin A BhuiyanDepartment of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Shannon ZhenF. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0009-0007-7446-3074
Qing WangProgram in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Riki KawaguchiProgram in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Samuel BungaLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.
Daniel G TaubF. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0363-6031
M Carmen Ruiz-CanteroDepartment of Pharmacology and Neurosciences Institute (Biomedical Research Center) and Biosanitary Research Institute ibs.GRANADA, University of Granada, Granada, Spain.
Candace Tong-LiF. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2733-5225
Nicholas AndrewsSalk Institute for Biological Studies, La Jolla, CA, USA.
Masakazu KotodaDepartment of Anesthesiology, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
William RenthalDepartment of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Peter K SorgerLaboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3364-1838
Clifford J WoolfF. M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA. clifford.woolf@childrens.harvard.edu.ORCID http://orcid.org/0000-0002-6636-3897

Funding

Unravelling Mechanisms and Novel Therapeutic Targets for Peripheral Neuropathy and Neuropathic Pain (Diversity Supplement)R35NS105076 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WOOLF, CLIFFORD J · 2018 to 2025
$9.5M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
NICHD NIH HHS P50 HD105351NINDS NIH HHS R35 NS105076United States Department of Defense | Defense Advanced Research Projects Agency (DARPA) HR0011-19-2-0022United States Department of Defense | Defense Advanced Research Projects Agency (DARPA) W911NF-20-1-0255U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R35NS105076
6 · The paper itself

Abstract

Inflammatory pain results from the heightened sensitivity and reduced threshold of nociceptor sensory neurons due to exposure to inflammatory mediators. However, the cellular and transcriptional diversity of immune cell and sensory neuron types makes it challenging to decipher the immune mechanisms underlying pain. Here we used single-cell transcriptomics to determine the immune gene signatures associated with pain development in three skin inflammatory pain models in mice: zymosan injection, skin incision and ultraviolet burn. We found that macrophage and neutrophil recruitment closely mirrored the kinetics of pain development and identified cell-type-specific transcriptional programs associated with pain and its resolution. Using a comprehensive list of potential interactions mediated by receptors, ligands, ion channels and metabolites to generate injury-specific neuroimmune interactomes, we also uncovered that thrombospondin-1 upregulated by immune cells upon injury inhibited nociceptor sensitization. This study lays the groundwork for identifying the neuroimmune axes that modulate pain in diverse disease contexts.

Indexed as

NociceptorsPainAnimalsDisease Models, AnimalGene Expression ProfilingInflammationMacrophagesMaleMiceMice, Inbred C57BLNeuroimmunomodulationNeutrophilsSingle-Cell AnalysisSkinThrombospondin 1TranscriptomeThrombospondin 1Zymosan

Identifiers

PMID38806708
PMCPMC11224023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.